Life Science Company News

Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Korro Bio Appoints Dr. Rachel Meyers to Board of Directors

Read more ››
By: GlobeNewswire - 28 Nov 2023

eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin in Combination with Fulvestrant and Abemaciclib for Treatment of ER+/HER2- Advanced Metastatic Breast Cancer

Read more ››
By: GlobeNewswire - 28 Nov 2023

Erasca Achieves Key Milestones for Naporafenib and ERAS-801 Programs and Extends Cash Runway

Read more ››
By: GlobeNewswire - 28 Nov 2023

Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit

Read more ››
By: GlobeNewswire - 28 Nov 2023

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

Read more ››
By: GlobeNewswire - 28 Nov 2023

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Upgrading at Ecuador Center (GKCE) with State-of-the-Art Gamma Knife ICON

Read more ››
By: GlobeNewswire - 28 Nov 2023

Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Read more ››
By: GlobeNewswire - 28 Nov 2023

iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare

Read more ››
By: GlobeNewswire - 28 Nov 2023

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

Read more ››
By: GlobeNewswire - 28 Nov 2023

Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn

Read more ››
By: GlobeNewswire - 28 Nov 2023

Nanox Announces Third Quarter of 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 28 Nov 2023

DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update

Read more ››
By: GlobeNewswire - 28 Nov 2023

Ambrx Provides Update On APEX-01, an On-Going Phase 1 / 2 Dose Escalation Study Evaluating ARX517, a Proprietary PSMA-Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer

Read more ››
By: GlobeNewswire - 28 Nov 2023

Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment

Read more ››
By: GlobeNewswire - 28 Nov 2023

SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment

Read more ››
By: GlobeNewswire - 28 Nov 2023

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

Read more ››
By: GlobeNewswire - 28 Nov 2023

Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain

Read more ››
By: GlobeNewswire - 28 Nov 2023

Vaxcyte Appoints Jacks Lee to Board of Directors

Read more ››
By: GlobeNewswire - 28 Nov 2023

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

Read more ››
By: GlobeNewswire - 28 Nov 2023

Cerevance Announces Presentation at the 34th International Symposium on ALS/MND

Read more ››
By: GlobeNewswire - 28 Nov 2023
Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Enhance your business development with Biotechgate